tiprankstipranks
Trending News
More News >
Amplia Therapeutics Ltd. (AU:ATX)
OTHER OTC:ATX
Australian Market

Amplia Therapeutics (ATX) Financial Statements

Compare
23 Followers

Amplia Therapeutics Financial Overview

Amplia Therapeutics's market cap is currently AU$87.22M. The company's EPS TTM is AU$-0.01; its P/E ratio is -7.71; Amplia Therapeutics is scheduled to report earnings on November 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 3.78MAU$ 4.45MAU$ 1.19MAU$ 1.98MAU$ 1.53M
Gross ProfitAU$ 3.57MAU$ 4.01MAU$ 1.12MAU$ 1.98MAU$ 1.53M
Operating IncomeAU$ -6.52MAU$ -4.42MAU$ -7.48MAU$ -3.64MAU$ -3.88M
EBITDAAU$ -6.78MAU$ -4.48MAU$ -7.26MAU$ -3.64MAU$ -3.81M
Net IncomeAU$ -6.57MAU$ -4.50MAU$ -6.24MAU$ -3.64MAU$ -2.28M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 10.86MAU$ 3.39MAU$ 9.26MAU$ 14.61MAU$ 1.85M
Total AssetsAU$ 22.94MAU$ 14.85MAU$ 18.68MAU$ 24.48MAU$ 10.88M
Total DebtAU$ 13.89KAU$ 1.59MAU$ 2.27MAU$ 2.10MAU$ 0.00
Net DebtAU$ -10.85MAU$ -1.80MAU$ -6.99MAU$ -12.51MAU$ -1.85M
Total LiabilitiesAU$ 1.91MAU$ 3.43MAU$ 2.85MAU$ 2.64MAU$ 539.13K
Stockholders' EquityAU$ 21.02MAU$ 11.42MAU$ 15.84MAU$ 21.85MAU$ 10.34M
Cash Flow
Free Cash FlowAU$ -6.89MAU$ -5.13MAU$ -5.31MAU$ -4.42MAU$ -2.92M
Operating Cash FlowAU$ -6.89MAU$ -5.13MAU$ -5.29MAU$ -4.40MAU$ -2.92M
Investing Cash FlowAU$ -2.07KAU$ -2.23KAU$ -58.42KAU$ -26.64KAU$ -5.35K
Financing Cash FlowAU$ 14.32MAU$ -772.98KAU$ -84.22KAU$ 17.19MAU$ 3.66M
Currency in AUD

Amplia Therapeutics Earnings and Revenue History

Amplia Therapeutics Debt to Assets

Amplia Therapeutics Cash Flow

Amplia Therapeutics Forecast EPS vs Actual EPS